Home LiteratureArticle Details
PMID: 1313911 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Relationship of eukaryotic initiation factor 3 to poliovirus-induced p220 cleavage activity.

Journal of virology ·Vol. 66 ·No. 5 ·1992-05-00 ·Pages 2943-51

Wyckoff EE, Lloyd RE, Ehrenfeld E

Abstract

The cleavage of the p220 subunit of eukaryotic initiation factor 4F (eIF-4F) that is induced by the poliovirus protease 2A has been shown previously to require another translation initiation factor, eIF-3. The role of eIF-3 in this cleavage reaction, however, is not known. An antiserum was raised against human eIF-3 and used to analyze the eIF-3 subunit composition in poliovirus-infected and uninfected HeLa cells and after incubation of eIF-3 in vitro with viral 2A protease. No evidence for 2Apro-dependent cleavage of any eIF-3 subunit was detected. Infected cells contain an activity that catalyzes the cleavage of p220 to a specific set of cleavage products. This activity is thought to be an activated form of a latent cellular protease. The p220-specific cleavage activity was partially purified. It was resolved from eIF-3 by both gel filtration and anion-exchange chromatography. Neither intact eIF-3 nor any detectable subunits of eIF-3 were found to copurify with the p220-specific cleavage activity. The latter activity behaves as a protein of 55,000 to 60,000 molecular weight and is inhibited by alkylating agents and metals, which indicates the presence of essential thiol groups. When this activity was incubated with partially purified p220, cleavage occurred only in the presence of eIF-3. Thus, eIF-3 appears to play a role in the p220 cleavage cascade which is subsequent to the 2Apro-induced activation of the p220-specific protease.

MeSH Terms
Cell Extracts Cysteine Endopeptidases/isolation & purification,metabolism Enzyme Activation Eukaryotic Initiation Factor-3 HeLa Cells Humans Macromolecular Substances Models, Biological Peptide Initiation Factors/isolation & purification,metabolism Poliomyelitis/metabolism Poliovirus/enzymology Protease Inhibitors Sulfhydryl Compounds/metabolism Viral Proteins
Chemicals
Cell Extracts Eukaryotic Initiation Factor-3 Macromolecular Substances Peptide Initiation Factors Protease Inhibitors Sulfhydryl Compounds Viral Proteins Cysteine Endopeptidases picornain 2A, Picornavirus
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Wyckoff E E
Department of Cellular, Viral, and Molecular Biology, University of Utah School of Medicine, Salt Lake City 84132.
Lloyd R E
Ehrenfeld E
References (48)
48 references, click to expand
  1. Immunoblot analysis of the structure of protein synthesis initiation factor eIF3 from HeLa cells.
    Arch Biochem Biophys. 1990 Jan;276(1):6-11 PMID: 2297231
  2. A region of the 5' noncoding region of foot-and-mouth disease virus RNA directs efficient internal initiation of protein synthesis within cells: involvement with the role of L protease in translational control.
    J Virol. 1990 Nov;64(11):5389-95 PMID: 2170677
  3. Dissociation of double-stranded polynucleotide helical structures by eukaryotic initiation factors, as revealed by a novel assay.
    Biochemistry. 1989 May 30;28(11):4729-34 PMID: 2548591
  4. Calmodulin-binding proteins as calpain substrates.
    Biochem J. 1989 Sep 15;262(3):693-706 PMID: 2556106
  5. Nomenclature of initiation, elongation and termination factors for translation in eukaryotes. Recommendations 1988. Nomenclature Committee of the International Union of Biochemistry (NC-IUB).
    Eur J Biochem. 1989 Dec 8;186(1-2):1-3 PMID: 2598922
  6. Isolation and structural characterization of cap-binding proteins from poliovirus-infected HeLa cells.
    J Virol. 1985 May;54(2):515-24 PMID: 2985814
  7. Cleavage of the cap binding protein complex polypeptide p220 is not effected by the second poliovirus protease 2A.
    Virology. 1986 Apr 15;150(1):299-303 PMID: 3006342
  8. Poliovirus mutant that does not selectively inhibit host cell protein synthesis.
    Mol Cell Biol. 1985 Nov;5(11):2913-23 PMID: 3018486
  9. Monoclonal antibody-aided characterization of cellular p220 in uninfected and poliovirus-infected HeLa cells: subcellular distribution and identification of conformers.
    J Virol. 1987 Sep;61(9):2702-10 PMID: 3039164
  10. Cap recognition and the entry of mRNA into the protein synthesis initiation cycle.
    Trends Biochem Sci. 1988 Feb;13(2):52-6 PMID: 3238751
  11. Effect of poliovirus double-stranded RNA on viral and host-cell protein synthesis.
    Proc Natl Acad Sci U S A. 1974 Jun;71(6):2440-4 PMID: 4366768
  12. Two forms of purified m7G-cap binding protein with different effects on capped mRNA translation in extracts of uninfected and poliovirus-infected HeLa cells.
    J Biol Chem. 1981 Aug 10;256(15):7691-4 PMID: 6267020
  13. Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex.
    J Biol Chem. 1982 Dec 25;257(24):14806-10 PMID: 6294080
  14. Immunochemical characterization of mammalian protein synthesis initiation factors.
    Biochemistry. 1982 Aug 31;21(18):4206-12 PMID: 6751385
  15. Capped mRNAs with reduced secondary structure can function in extracts from poliovirus-infected cells.
    Mol Cell Biol. 1982 Dec;2(12):1633-8 PMID: 14582204
  16. Relationship of p220 cleavage during picornavirus infection to 2A proteinase sequencing.
    J Virol. 1988 Nov;62(11):4216-23 PMID: 2845133
  17. Inhibition of the proteolysis of rat erythrocyte membrane proteins by a synthetic inhibitor of calpain.
    Biochem Biophys Res Commun. 1988 Dec 30;157(3):1117-23 PMID: 2849930
  18. Poliovirus protease does not mediate cleavage of the 220,000-Da component of the cap binding protein complex.
    Proc Natl Acad Sci U S A. 1985 May;82(9):2723-7 PMID: 2986132
  19. Poliovirus protease 3C (P3-7c) does not cleave P220 of the eucaryotic mRNA cap-binding protein complex.
    J Virol. 1985 Aug;55(2):489-93 PMID: 2991572
  20. Two-dimensional gel analyses of the 24-kDa cap binding protein from poliovirus-infected and uninfected HeLa cells.
    Virology. 1986 Jul 30;152(2):497-501 PMID: 3014728
  21. Regulation of translation by poliovirus.
    Adv Virus Res. 1987;33:175-204 PMID: 3035905
  22. Restriction of translation of capped mRNA in vitro as a model for poliovirus-induced inhibition of host cell protein synthesis: relationship to p220 cleavage.
    J Virol. 1987 Aug;61(8):2480-8 PMID: 3037110
  23. Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220.
    J Virol. 1987 Sep;61(9):2711-8 PMID: 3039165
  24. ATP-dependent unwinding of messenger RNA structure by eukaryotic initiation factors.
    J Biol Chem. 1985 Jun 25;260(12):7651-8 PMID: 3838990
  25. Demonstration in vitro that eucaryotic initiation factor 3 is active but that a cap-binding protein complex is inactive in poliovirus-infected HeLa cells.
    J Virol. 1984 Sep;51(3):832-7 PMID: 6088805
  26. Purification of a factor that restores translation of vesicular stomatitis virus mRNA in extracts from poliovirus-infected HeLa cells.
    Proc Natl Acad Sci U S A. 1980 Feb;77(2):770-4 PMID: 6244584
  27. Association of cap-binding protein with eucaryotic initiation factor 3 in initiation factor preparations from uninfected and poliovirus-infected HeLa cells.
    J Virol. 1982 Apr;42(1):200-7 PMID: 6283140
  28. Protein synthesis eukaryotic initiation factors 4A and 4B are not altered by poliovirus infection of HeLa cells.
    J Biol Chem. 1983 Jun 10;258(11):7236-9 PMID: 6304085
  29. Involvement of eukaryotic initiation factor 4A in the cap recognition process.
    J Biol Chem. 1983 Sep 25;258(18):11398-403 PMID: 6604056
  30. Characterization of eukaryotic initiation factor 4A, a protein involved in ATP-dependent binding of globin mRNA.
    J Biol Chem. 1982 May 10;257(9):5246-52 PMID: 7068683
  31. Poliovirus-induced inhibition of polypeptide initiation in vitro on native polyribosomes.
    Proc Natl Acad Sci U S A. 1976 Jun;73(6):1834-8 PMID: 180525
  32. Alterations in initiation factor activity from poliovirus-infected HeLa cells.
    J Biol Chem. 1979 Nov 10;254(21):10973-8 PMID: 227856
  33. cis- and trans-cleavage activities of poliovirus 2A protease expressed in Escherichia coli.
    J Virol. 1991 Nov;65(11):6077-83 PMID: 1656087
  34. Translational control in mammalian cells.
    Annu Rev Biochem. 1991;60:717-55 PMID: 1883206
  35. Variations in cap-binding complexes from uninfected and poliovirus-infected HeLa cells.
    J Biol Chem. 1990 May 5;265(13):7492-500 PMID: 2159001
  36. Eukaryotic initiation factor 3 is required for poliovirus 2A protease-induced cleavage of the p220 component of eukaryotic initiation factor 4F.
    Proc Natl Acad Sci U S A. 1990 Dec;87(24):9529-33 PMID: 2175904
  37. Human immunodeficiency virus tat-activated expression of poliovirus protein 2A inhibits mRNA translation.
    Proc Natl Acad Sci U S A. 1989 Apr;86(7):2143-6 PMID: 2538833
  38. Inhibition of translation in cells infected with a poliovirus 2Apro mutant correlates with phosphorylation of the alpha subunit of eucaryotic initiation factor 2.
    J Virol. 1989 Dec;63(12):5069-75 PMID: 2555543
  39. Purification and partial characterization of poliovirus protease 2A by means of a functional assay.
    J Virol. 1988 Apr;62(4):1243-50 PMID: 2831385
  40. Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex.
    J Virol. 1988 Nov;62(11):4407-9 PMID: 2845152
  41. Control of protein synthesis in extracts from poliovirus-infected cells. I. mRNA discrimination by crude initiation factors.
    J Virol. 1978 May;26(2):510-21 PMID: 207899
  42. A polypeptide in eukaryotic initiation factors that crosslinks specifically to the 5'-terminal cap in mRNA.
    Proc Natl Acad Sci U S A. 1978 Oct;75(10):4843-7 PMID: 217002
  43. Translation of poliovirus RNA in vitro: changes in cleavage pattern and initiation sites by ribosomal salt wash.
    Virology. 1979 Sep;97(2):396-405 PMID: 224589
  44. Characterization of poliovirus 2A proteinase by mutational analysis: residues required for autocatalytic activity are essential for induction of cleavage of eukaryotic initiation factor 4F polypeptide p220.
    J Virol. 1991 Aug;65(8):4226-31 PMID: 1649327
  45. Substrate requirements of a human rhinoviral 2A proteinase.
    Virology. 1991 Mar;181(1):46-54 PMID: 1847268
  46. Identification of essential amino acid residues in the functional activity of poliovirus 2A protease.
    Virology. 1991 Jun;182(2):615-25 PMID: 1850921
  47. The p220 component of eukaryotic initiation factor 4F is a substrate for multiple calcium-dependent enzymes.
    Biochemistry. 1990 Oct 30;29(43):10055-61 PMID: 1980214
  48. Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F.
    Mol Cell Biol. 1990 Mar;10(3):1134-44 PMID: 2304461
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1992-05-00
Pages
2943-51
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC241053
Subset
IM
Grants
NIAID NIH HHS · AI-12387 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com